TODAY’S PAPER | November 23, 2026 | EPAPER

Cough syrups under tight scrutiny

.


Our Correspondent November 23, 2026 Less than a minute read
Drug Regulatory Authority of Pakistan

ISLAMABAD:

The Drug Regulatory Authority of Pakistan (DRAP) has directed pharmaceutical firms to strengthen quality control and conduct mandatory testing of raw materials used in cough syrups and other oral liquid medicines to prevent contamination with toxic chemicals.

In an advisory issued ahead of the winter season, DRAP highlighted the need for strict compliance with Good Manufacturing Practices (GMP), given the expected increase in demand and production of cough syrups and other oral liquid preparations.

The authority directed manufacturers to procure critical raw materials.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ